Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
Hansen, A.R., Massard, C., Ott, P.A., Haas, N.B., Lopez, J.S., Ejadi, S., Wallmark, J.M., Keam, B., Delord, J.-P., Aggarwal, R., Gould, M., Yang, P., Keefe, S.M., Piha-Paul, S.A.
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
KEYNOTE-826: A phase III randomized study of chemotherapy with or without pembrolizumab for first-line treatment of persistent, recurrent, or metastatic cervical cancer
Fujiwara, K., Shapira-Frommer, R., Alexandre, J., Monk, B., Fehm, T., Colombo, N., Caceres, M.V., Hasegawa, K., Dubot, C., Li, J.J., Stein, K., Keefe, S.M., Tewari, K.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
LBA2 Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase III KEYNOTE-826 study
Colombo, N., Dubot, C., Lorusso, D., Cáceres, V., Hasegawa, K., Shapira-Frommer, R., Tewari, K.S., Salman, P., Hoyos, E., Yañez, E., Gumus, M., Olivera Hurtado de Mendoza, M., Samouëlian, V., Castonguay, V., Arkhipov, A., Toker, S., Li, K., Keefe, S.M., Monk, B.J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA¬-nonmutated advanced epithelial ovarian cancer
Fujiwara, K., Vergote, I.B., Sehouli, J., Salutari, V., Zola, P., Madry, R., Wenham, R.M., Korach, J., Pautier, P., Cibula, D., Lheureux, S., Hasegawa, K., Kim, B.-G., Lai, C.-H., Gonzalez-Martinez, A., Liu, Q., Keefe, S.M., Puglisi, M., Topuz, S.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial
Keefe, S.M., Hoffman-Censits, J., Cohen, R.B., Mamtani, R., Heitjan, D., Eliasof, S., Nixon, A., Turnbull, B., Garmey, E.G., Gunnarsson, O., Waliki, M., Ciconte, J., Jayaraman, L., Senderowicz, A., Tellez, A.B., Hennessy, M., Piscitelli, A., Vaughn, D., Smith, A., Haas, N.B.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer
Marth, C., Vulsteke, C., Rubio, M.J., Makker, V., Braicu, E.I., McNeish, I.A., Radoslaw, M., Ayhan, A., Hasegawa, K., Wu, X., Dutta, L., Xu, C., Keefe, S.M., Lee, J., Pignata, S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1063TiP - ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer
Marth, C., Vulsteke, C., Rubio, M.J., Makker, V., Braicu, E.I., McNeish, I.A., Radoslaw, M., Ayhan, A., Hasegawa, K., Wu, X., Dutta, L., Xu, C., Keefe, S.M., Lee, J., Pignata, S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Pembrolizumab (pembro) as first-line therapy in cisplatin-ineligible advanced urothelial cancer (UC): Outcomes from KEYNOTE-052 in senior patients (pts) with poor performance status
Grivas, P., Plimack, E., Balar, A.V., Castellano, D., O'Donnell, P.H., Bellmunt, J., Powles, T., Hahn, N., de Wit, R., Bajorin, D., Ellison, M.C., Frenkl, T., Keefe, S.M., Vuky, J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Gene expression profile (GEP) and survival among patients with advanced ovarian cancer
Høgdall, E., Høgdall, C.K., Vo, P.-T., Zhou, W., Huang, L., Marton, M., Keefe, S.M., Busch-Sørensen, M., Sørensen, S.M., Georgsen, J., Mejlgaard, E., Nedergaard, L., Steiniche, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A novel framework for evaluating biomarker response relationships in immuno-oncology (IO)
Evelhoch, J.L., Mogg, R., Cristescu, R., Aurora-Garg, D., Chow, L.Q., Loi, S., Catenacci, D.V.T., Matulonis, U.A., Ott, P.A., Antonarakis, E.S., Poehlein, C.H., Joe, A., Keefe, S.M., Kang, P., Karantza, V., Cheng, J., Rubin, E.H.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article